English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine MedTech
康基醫療與Knight Bidco聯合發佈私有化建議計劃文件
Oct 13, 2025 10:14 HKT
長風藥業於香港聯合交易所主板成功上市
Oct 08, 2025 17:38 HKT
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
Sep 28, 2025 15:00 HKT
康哲药业(867.HK;8A8.SG)创新药磷酸芦可替尼乳膏AD中国三期临床取得积极结果
Sep 28, 2025 11:33 HKT
康哲藥業(867.HK;8A8.SG)創新藥磷酸蘆可替尼乳膏AD中國三期臨床取得積極結果
Sep 28, 2025 11:33 HKT
WORK Medical enters strategic partnerships in bid to explore RWA initiatives
Sep 24, 2025 22:30 HKT
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies
Sep 23, 2025 12:15 HKT
康哲药业就用于破伤风被动免疫和狂犬病被动免疫的两款创新生物制剂达成合作
Sep 23, 2025 11:16 HKT
康哲藥業就用於破傷風被動免疫和狂犬病被動免疫的兩款創新生物製劑達成合作
Sep 23, 2025 11:16 HKT
中國銀河證券重申現代牙科(03600.HK)「增持」評級 目標價調升至6.88港元
Sep 18, 2025 16:30 HKT
CGSI Reiterates 'Add' Rating on Modern Dental (03600.HK) with Raised Target Price of HK$6.88
Sep 18, 2025 16:30 HKT
HKTDC releases research report on biomedicine, Industry development drives GBA global tech leadership
Sep 15, 2025 15:19 HKT
現代牙科集團2025年中期淨利潤升34.7%
Aug 29, 2025 09:25 HKT
Modern Dental Group Reports 34.7% Surge in 1H2025 Net Profit
Aug 29, 2025 09:25 HKT
现代牙科集团2025年中期净利润升34.7%
Aug 29, 2025 09:25 HKT
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers
Aug 19, 2025 15:00 HKT
康哲药业(867.HK,8A8.SG)上半年营收净利双升 战略转型跑出增长新动能
Aug 19, 2025 11:53 HKT
康哲藥業(867.HK,8A8.SG)上半年營收淨利雙升 戰略轉型跑出增長新動能
Aug 19, 2025 11:53 HKT
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 11:27 HKT
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景
Aug 13, 2025 09:27 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: